Lumida
/DOUG
⌘K
Douglas Elliman Inc

Douglas Elliman Inc

DOUG
$1.88USD-2.08%-0.04 today

MARKET CAP

170.9M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$2
$3

AI Summary

Stalk
TrimMedium

The asset remains in a Stage 4 decline with failed rallies at declining EMAs, confirming a bearish medium-term bias. Short-term price is neutral, trading sideways below sloping EMAs and lacking a clear bounce signal. Execution should be deferred and focused on trimming into rallies back into the 9 EMA and 21 EMA zone for rejection at resistance.

  • Q1 2025 revenue rose 27% YoY to $253.4 M, best first quarter since 2022
  • Development marketing revenue surged 222% YoY to $21.1 M, with $28.3 B project pipeline
  • Negative earnings yield and Q4 2025 net loss of $15.2 M signal profitability risks
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Douglas Elliman, Inc. (NYSE: DOUG) is a premier luxury real estate brokerage firm with a strong presence in high-end residential markets across the United States. The company not only focuses on residential real estate, but also engages in development marketing and ancillary services, such as title and escrow. Positioned within the luxury market segment, Douglas Elliman aims to capitalize on the growing demand for luxury residences amidst challenging economic conditions. Recent initiatives, including the launch of Element Capital, an innovative mortgage platform, reflect the company's effort to enhance client engagement and streamline transactions in a highly competitive landscape.

Bull says

  • Q1 2025 revenue rose 27% YoY to $253.4 M, best first quarter since 2022
  • Development marketing revenue surged 222% YoY to $21.1 M, with $28.3 B project pipeline
  • Net loss narrowed to $6 M in Q1 from $41.5 M a year ago, reflecting cost controls
  • Average price per home sale climbed to $2 M in Q1, highlighting luxury demand
  • Element Capital launch plus France and Monaco expansion broaden growth avenues
  • Book-to-price above peers and 11% dividend yield suggest undervaluation

Bear says

  • Negative earnings yield and Q4 2025 net loss of $15.2 M signal profitability risks
  • Inflation-driven costs pushed average operating losses to ~$14 M in 2025
  • Heavy reliance on luxury segment makes revenue sensitive to rate hikes
  • Momentum is weak and price volatility remains elevated, deterring cautious investors
  • High short interest and low institutional ownership reflect market skepticism
  • Weak profitability factors and cost pressures threaten margin recovery

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 07-14-2026bullish

Transcript signals

Bull points

  • In Q4, cash flow from operations was $10.3 million, up approximately $23 million compared to the prior year.
  • For the full year, we generated $32.1 million in cash flow from operations compared to just $1 million in 2023.
  • $15.5 million in 2024 compared to a negative $22 million a year ago, an improvement of $38 million year over year.

Bear points

  • While I am a bit disappointed by our fourth quarter bookings performance, I'm still pleased with the strength of the first three quarters and with where we landed for the full year.
  • First, while I ultimately believe the changes in Washington will be a net positive for our space, there is uncertainty associated with how this administration will address the funding of healthcare, which could have a slight impact on the timing of deals.
  • as we scale up and see deals getting larger, the concentrations of bookings in those specific contracts could provide an increase in short-term volatility.
Read full transcript analysis ›